These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1708872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
    Aizawa Y, Chinushi M, Naitoh N, Shibata A.
    Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM, Spielman SR, Webb CR, Sokoloff NM, Rae AP, Horowitz LN.
    Am J Cardiol; 1985 Aug 01; 56(4):277-84. PubMed ID: 4025166
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The use of the block cycle length as a safe and efficient means of interrupting sustained ventricular tachycardia and its pharmacological modification.
    Ohira K, Niwano S, Furushima H, Taneda K, Chinushi M, Aizawa Y.
    Pacing Clin Electrophysiol; 1998 Sep 01; 21(9):1686-92. PubMed ID: 9744429
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ, Easley AR, Mann DE.
    Am J Cardiol; 1987 Jun 01; 59(15):1319-24. PubMed ID: 3109228
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
    Rials SJ, Britchkow D, Marinchak RA, Kowey PR.
    Clin Cardiol; 2000 Mar 01; 23(3):171-4. PubMed ID: 10761804
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
    Rae AP, Sokoloff NM, Webb CR, Spielman SR, Greenspan AM, Horowitz LN.
    J Am Coll Cardiol; 1985 Aug 01; 6(2):410-6. PubMed ID: 4019928
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
    Interian A, Zaman L, Velez-Robinson E, Kozlovskis P, Castellanos A, Myerburg RJ.
    J Am Coll Cardiol; 1991 Jun 01; 17(7):1581-6. PubMed ID: 2033190
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML, Miles WM, Luck JC, Klein LS, Prystowsky EN.
    Circulation; 1993 Mar 01; 87(3):783-92. PubMed ID: 8443899
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients.
    Waspe LE, Waxman HL, Buxton AE, Josephson ME.
    Am J Cardiol; 1983 Apr 01; 51(7):1175-81. PubMed ID: 6340451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.